Dataset Information


ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes.

ABSTRACT: The HMG-CoA reductase degradation protein 1 (HRD1) has been identified as a key enzyme for endoplasmic reticulum-associated degradation of misfolded proteins, but its organ-specific physiological functions remain largely undefined. Here we show that mice with HRD1 deletion specifically in the liver display increased energy expenditure and are resistant to HFD-induced obesity and liver steatosis and insulin resistance. Proteomic analysis identifies a HRD1 interactome, a large portion of which includes metabolic regulators. Loss of HRD1 results in elevated ENTPD5, CPT2, RMND1, and HSD17B4 protein levels and a consequent hyperactivation of both AMPK and AKT pathways. Genome-wide mRNA sequencing revealed that HRD1-deficiency reprograms liver metabolic gene expression profiles, including suppressing genes involved in glycogenesis and lipogenesis and upregulating genes involved in glycolysis and fatty acid oxidation. We propose HRD1 as a liver metabolic regulator and a potential drug target for obesity, fatty liver disease, and insulin resistance associated with the metabolic syndrome.


PROVIDER: S-EPMC6131148 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6236331 | BioStudies
1969-12-31 | S-SCDT-EMBOJ-2018-98942 | BioStudies
2018-01-01 | S-EPMC6236336 | BioStudies
2019-01-01 | GSE113154 | GEO
1000-01-01 | S-EPMC5410327 | BioStudies
2019-01-01 | S-EPMC6914336 | BioStudies
1000-01-01 | S-EPMC6103995 | BioStudies
2017-01-01 | S-EPMC5665440 | BioStudies
2015-01-01 | S-EPMC4767476 | BioStudies
1000-01-01 | S-EPMC5454095 | BioStudies